Valuation: Caplin Point Laboratories Limited

Market Cap 20TCr 209.42Cr 183.1Cr 168.91Cr 155.27Cr 294.19Cr 299.22Cr 2.02TCr 791.2Cr 9.85TCr 786.47Cr 769.23Cr 34TCr P/E 2026
17.9x
P/E 2027 * 28.3x
Enterprise Value 20TCr 209.42Cr 183.1Cr 168.91Cr 155.27Cr 294.19Cr 299.22Cr 2.02TCr 791.2Cr 9.85TCr 786.47Cr 769.23Cr 34TCr EV / Sales 2026
5.23x
EV / Sales 2027 * 8.1x
Free-Float
26.39%
Yield 2026 *
-
Yield 2027 * 0.15%
1 day-1.06%
1 week-0.05%
Current month-0.23%
1 month+10.19%
3 months+48.45%
6 months+43.47%
Current year+42.54%
1 week 2,566.1
Extreme 2566.1
2,699
1 month 2,325.4
Extreme 2325.4
2,699
Current year 1,500.3
Extreme 1500.3
2,699
1 year 1,500.3
Extreme 1500.3
2,699
3 years 821.4
Extreme 821.4
2,699
5 years 575
Extreme 575
2,699
10 years 176.2
Extreme 176.2
2,699
Manager TitleAgeSince
Chief Executive Officer 71 28/03/2015
Director of Finance/CFO - 19/02/2016
Chief Administrative Officer - -
Director TitleAgeSince
Chairman 73 27/01/2010
Director/Board Member - 05/11/2025
Director/Board Member 71 28/03/2015
Change 5-day change 1-year change 3-year change Capi.($)
-0.97%-0.05% - - 210.34Cr
-0.22%+0.39%+14.42%+80.61% 4.85TCr
+1.28%+0.27%+68.51%+113.96% 3.57TCr
-0.15%-0.46%-2.78%+38.93% 1.21TCr
+0.04%-0.11%+19.49%+91.97% 1.18TCr
+1.53%+1.15%+32.83%+126.50% 918.79Cr
-0.59%-3.06%+43.01%-5.79% 705.8Cr
-0.17%0.00%+18.91%+37.26% 701Cr
-0.68%+0.65%+3.50%+224.89% 677.23Cr
+6.39%+7.36%-16.52%+20.63% 597.99Cr
Average +0.63%+0.42%+20.15%+80.99% 1.6TCr
Weighted average by Cap. +0.48%-0.27%+27.78%+87.17%

Financials

2026 2027 *
Net sales 2.13TCr 22Cr 19Cr 18Cr 16Cr 31Cr 32Cr 212.93Cr 84Cr 1.04TCr 83Cr 81Cr 3.58TCr 2.49TCr 26Cr 23Cr 21Cr 19Cr 36Cr 37Cr 248.97Cr 98Cr 1.22TCr 97Cr 95Cr 4.19TCr
Net income 616.2Cr 6.4Cr 5.6Cr 5.16Cr 4.75Cr 9Cr 9.15Cr 62Cr 24Cr 301.18Cr 24Cr 24Cr 1.04TCr 712.75Cr 7.41Cr 6.48Cr 5.97Cr 5.49Cr 10Cr 11Cr 71Cr 28Cr 348.37Cr 28Cr 27Cr 1.2TCr
Net Debt - -
Logo Caplin Point Laboratories Limited
Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.
Employees
3,966
Date Price Change Volume
16/26/16 2,622.40 -0.97% 9,689
15/26/15 ₹2,648.10 -0.39% 93,049
14/26/14 ₹2,658.40 +1.62% 1,32,461
13/26/13 ₹2,616.10 +1.26% 72,386
10/26/10 ₹2,583.60 -1.44% 1,32,345
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2,651.05INR
Average target price
2,505.00INR
Spread / Average Target
-5.51%

Quarterly revenue - Rate of surprise